About Copmed Pharmaceuticals Private Limited
Data last updated:
Copmed Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India, a subsidiary of Mankind Pharma Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 September 1988 and has been in existence for over 38 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1988PTC033151. Its GSTIN is 02AAACC6076B2Z9 (Himachal Pradesh). The company holds 8 GST registrations, of which 5 are active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹96 Lakh. It is led by directors including Jagmohan Sharma (Whole-Time Director) and Abhay Kumar Srivastava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 208 Okhla Industrial Estate Phase – III, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2025, the company reported a revenue of ₹437.53 Cr, a decline of 5% compared to the previous year. For the same year it recorded a net profit of ₹32.67 Cr (net margin 7.5%) and EBITDA of ₹48.48 Cr (EBITDA margin 11.1%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 9% over five years.
The company has about 349 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Copmed Pharmaceuticals. As per MCA filings, the company has open charges of ₹54.85 Cr and satisfied charges of ₹25.3 Cr on record. Court records list 11 cases involving the company, including 7 filed by the company and 4 filed against it; 2 cases are pending. The company has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹90 Lakh; the latest was in October 2017. Its 8 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Biophore India Pharmaceuticals Private Limited with revenue of ₹457 Cr. The company has 9 MSME Form 1 returns on record between 2022 and 2024, listing 2,585 overdue payments to 69 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website copmedpharma.com.
Company details
Contact details
Copmed Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is copmedpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address208 Okhla Industrial Estate Phase – III, New Delhi, Delhi, India – 110020
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Copmed Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Copmed Pharmaceuticals operates one associated brand: Copmed Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces high-quality pharmaceutical products including tablets, capsules, syrups, and injectables. | copmedpharma.com |
Business activity
The main business activities of Copmed Pharmaceuticals are manufacturing and professional, scientific and technical. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and scientific research and development. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Copmed Pharmaceuticals Private Limited, buy the company report.
Financials of Copmed Pharmaceuticals Private Limited
FY 2025 filings availableCopmed Pharmaceuticals Private Limited reported revenue of ₹437.53 Cr (down 5% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 5% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 9%. EBITDA fell 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹48.48 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹32.67 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.1% | ||||
| Net Profit Margin | 7.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Copmed Pharmaceuticals Private Limited, buy the company report.
Board of directors of Copmed Pharmaceuticals Private Limited
Copmed Pharmaceuticals has 6 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abhay Kumar Srivastava Also directs: Relax Pharmaceuticals Private Limited, Sirmour Remedies Private Limited, Mankind Medicare Private Limited and 5 more | Director | 01 Mar 2021 | 5 Years 7 Months | Current |
| Akhlas Ahmed Also directs: Relax Pharmaceuticals Private Limited, Sirmour Remedies Private Limited, Mankind Medicare Private Limited and 5 more | Director | 01 Mar 2021 | 5 Years 7 Months | Current |
| Veer Singh Pal | Director | 31 Jul 2009 | 17 Years 2 Months | Current |
| Jagmohan Sharma | Whole-Time Director | 08 Aug 2024 | 2 Years 2 Months | Current |
| Bhupendra Kaushik Also directs: Relax Pharmaceuticals Private Limited, BKB & Associates LLP, Alstone Textiles (India) Limited and 4 more | Director | 26 Mar 2021 | 5 Years 7 Months | Current |
| Anju Kumari Jha Also directs: Relax Pharmaceuticals Private Limited, Qualitek Starch Private Limited, Mankind Life Sciences Private Limited and 5 more | Director | 26 Mar 2021 | 5 Years 7 Months | Current |
Peer comparison
Copmed Pharmaceuticals Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biophore India Pharmaceuticals Private Limited | ₹457 Cr (FY 2025) | 18.0% | Hyderabad, Telangana, India | |||
| Fredun Pharmaceuticals Ltd | ₹456.27 Cr (FY 2025) | 31.0% | Mumbai, Maharashtra, India | |||
| Hab Pharmaceuticals and Research Limited | ₹448.72 Cr (FY 2025) | 19.0% | Mumbai, Maharashtra, India | |||
| Medispray Laboratories Private Limited | ₹444.46 Cr (FY 2025) | 7.0% | Goa, India | |||
| Copmed Pharmaceuticals Private Limitedthis company | ₹437.53 Cr (FY 2025) | ₹32.67 Cr | 7.5% | -5.0% | 349 | New Delhi, Delhi, India |
| Hazelo Lab Private Limited | ₹431.64 Cr (FY 2024) | 3.0% | Chityal, Telangana, India | |||
| Zydus Hospira Oncology Private Limited | ₹430.96 Cr (FY 2025) | 66.0% | Village Matoda Tal Sanand, Gujarat, India | |||
| Halewood Laboratories Private Limited | ₹430.29 Cr (FY 2025) | 20.0% | Ahmedabad, Gujarat, India | |||
| Milan Laboratories (India) Private Limited | ₹429.23 Cr (FY 2024) | 42.0% | Thane, Maharashtra, India |
To see the full peer comparison of Copmed Pharmaceuticals Private Limited, buy the company report.
Auditor
Copmed Pharmaceuticals Private Limited is audited by S.R. Batliboi & Co. LLP for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.R. Batliboi & Co. LLP | FY 2024 | 301003E/E300005 |
Shareholding
The shareholding of Copmed Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Copmed Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Sep 2021 | 100481953 | Others | ₹39.78 Lakh | Open | |
| 22 Sep 2021 | 100481968 | Others | ₹45.31 Lakh | Open | |
| 30 Sep 2010 | 10248378 | Hdfc Bank Limited | ₹54 Cr | Open | |
| 30 Sep 2010 | 10248381 | Hdfc Bank Limited | ₹20 Cr | Satisfied | |
| 05 Sep 2009 | 10175884 | Member Secretary | ₹30 Lakh | Satisfied |
To see the full charge records of Copmed Pharmaceuticals Private Limited, buy the company report.
Total charge records: 6 View all charges
Deals & funding
Copmed Pharmaceuticals Private Limited has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹90 Lakh; the latest was in October 2017.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2017 | Secondary share transfer | Undisclosed | Buyer: Mankind Pharma Limited Seller: 3 individuals |
| Dec 2008 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 4 individuals |
| Feb 2007 | Funding round | ₹90 Lakh | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Copmed Pharmaceuticals Private Limited has 11 court cases on record: 7 filed by Copmed Pharmaceuticals, 4 filed against it. 2 cases are pending and 9 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 1 | 2 |
| High courts | 5 | 2 | 0 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 11)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Sirmaur, Himachal Pradesh | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, Moradabad, Uttar Pradesh | Criminal case | Filed against the company by Up State | Pending |
| High Court, HIMACHAL PRADESH | Criminal miscellaneous application | Filed against the company by an individual | Disposed |
| High Court, HIMACHAL PRADESH | Criminal miscellaneous application | Filed against the company by an individual | Disposed |
| High Court, HIMACHAL PRADESH | Interim or miscellaneous application | Filed by the company against an individual | Disposed |
To see the full case history of Copmed Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Copmed Pharmaceuticals Private Limited has 9 MSME Form 1 returns on record between 2022 and 2024, listing 2,585 overdue payments to 69 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 69)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| A to Z Packers | |||
| an individual supplier | |||
| an individual supplier | |||
| Jayanti Polymer |
To see the full MSME payment records of Copmed Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Copmed Pharmaceuticals Private Limited has a workforce of 349 employees on its EPFO records as of May 21, 2025, across 2 active EPFO establishments.
GST
Copmed Pharmaceuticals has 8 GST registrations: 5 active and 3 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAACC6076B2Z9 | Himachal Pradesh | Active | 01 Jul 2017 |
| 05AAACC6076B2Z3 | Uttarakhand | Active | 14 Jul 2017 |
| 19AAACC6076B1ZV | West Bengal | Active | 15 Nov 2018 |
| 29AAACC6076B1ZU | Karnataka | Active | 24 Nov 2018 |
To see the full GST registrations and return filing status of Copmed Pharmaceuticals Private Limited, buy the company report.
Recent activity
Copmed Pharmaceuticals Private Limited has 19 board changes on record since 2009: 6 appointments and 13 cessations. The latest: Jagmohan Sharma was appointed as Whole-Time Director on 08 Aug 2024.
22 earlier events are in the company report.
Frequently asked questions
Copmed Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 September 1988 (38+ years old) and is registered under CIN U74899DL1988PTC033151.
Copmed Pharmaceuticals has 6 current directors:
- Jagmohan Sharma - Whole-Time Director
- Abhay Kumar Srivastava - Director
- Akhlas Ahmed - Director
- Veer Singh Pal - Director
- Bhupendra Kaushik - Director
- Anju Kumari Jha - Director
The latest financial statements of Copmed Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Copmed Pharmaceuticals is 02AAACC6076B2Z9, registered in Himachal Pradesh. The company has 8 GST registrations in all, of which 5 are active and 3 are cancelled or inactive. Other active GSTINs include 05AAACC6076B2Z3 (Uttarakhand), 19AAACC6076B1ZV (West Bengal), 29AAACC6076B1ZU (Karnataka).
The CIN (Corporate Identification Number) of Copmed Pharmaceuticals is U74899DL1988PTC033151. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Copmed Pharmaceuticals has 11 court cases on record: 7 filed by the company and 4 filed against it. 2 are pending. Most are in the district courts.
Copmed Pharmaceuticals was incorporated on 13 September 1988, making it 38+ years old. It is registered with the Registrar of Companies, Delhi.
Copmed Pharmaceuticals has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹90 Lakh; the latest was in October 2017.
The peers of Copmed Pharmaceuticals by revenue are Biophore India Pharmaceuticals Private Limited, Fredun Pharmaceuticals Ltd, Hab Pharmaceuticals and Research Limited, Medispray Laboratories Private Limited, Hazelo Lab Private Limited and 3 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Jagmohan Sharma was appointed as Whole-Time Director on 08 Aug 2024. Jagmohan Sharma ceased to be Additional Director on 08 Aug 2024. Abhay Kumar Srivastava ceased to be Additional Director on 30 Nov 2021. Copmed Pharmaceuticals has 19 board changes on record in total.
Copmed Pharmaceuticals has 9 MSME Form 1 returns on record between 2022 and 2024, listing 2,585 overdue payments to 69 micro and small suppliers. The latest return was filed on 02 May 2024.
Copmed Pharmaceuticals can be reached through the website copmedpharma.com. Its registered office is in New Delhi, Delhi, India.